Abbott Laboratories
ABT · Healthcare · Health Care
Updated 25 min ago · data delayed ≥15 min
IconicScore
ProprietaryRanked #62 of 500 by Iconic Score · #9 of 59in its sector. IconicAlpha’s proprietary brand-intelligence metric — a multi-model blend of scale, market attention, category leadership, and AI-analyzed brand visibility.
Get the free morning email
The biggest IconicScore™ gainer and loser, plus the strongest and weakest sectors, in your inbox before the open. See a sample →
Price performance
Export history · AnalystThis insight is part of the Analyst tier — unlock the IconicScore vs. price overlay, side-by-side comparison, and CSV export.
Upgrade to AnalystThis is part of the Enterprise tier — benchmark your IconicScore against sector peers, claim your profile, and manage how your brand appears on the wall.
Upgrade to EnterpriseIconic Profile
Abbott Laboratories (ABT) is a global healthcare company with a market capitalization of $173.3 billion, specializing in the development and manufacturing of a broad range of medical devices, diagnostics, nutrition products, and branded pharmaceuticals. The company operates in various segments, including cardiovascular, diabetes care, and nutrition, positioning itself as a leader in innovative healthcare solutions. Abbott's extensive portfolio includes well-known products such as Freestyle Libre for glucose monitoring and Similac infant formula, catering to diverse health needs across different demographics. Its strong market presence and commitment to research and development underscore its importance in advancing healthcare technologies and improving patient outcomes, making it a key player in the evolving healthcare landscape.
IconicOracleAI™ Brief
Abbott Laboratories currently holds an Iconic Score of 59, reflecting a moderate brand presence amid a challenging healthcare sector. The company's recent announcement to spin out its nutrition business has garnered attention, while a decline in healthcare stocks may be impacting overall sentiment. Despite a market cap of $177.5 billion, Abbott's stock price has recently decreased by 3.41%, indicating some investor caution. However, the brand maintains strong visibility with a logo analysis score of 85/100.
AI-generated explanation of current score drivers. Not investment advice.
Enterprise tier: claim your logo to manage how your brand is represented.